分离德国/BavPat1/2020(病毒），NR-1_Vaccinia virus

NR-52370??SARS-Related Coronavirus 2, Isolate Germany/BavPat1/2020(Viruses)|SARS-Related Coronavirus 2|Isolate Germany/BavPat1/2020|-60°C or colder|R W?lfel, R EhmannAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2, Isolate Germany/BavPat1/2020, NR-52370.”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment. Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate Germany/BavPat1/2020 (also referred to as Germany/MUC-IMB1/2020 or Human/DEU/BavPat1-ChVir929/2020) was isolated from a sputum sample from a mildly symptomatic adult male patient identified as Patient One in the Bavarian cluster on January 28, 2020 in Bavaria, Germany. Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARS-CoV-2, isolate Germany/BavPat1/2020 is assigned lineage B and GISAID clade G using Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN) tool. The complete genome sequence of SARS-CoV-2, isolate Germany/BavPat1/2020 has been sequenced (GenBank: MT270101 and GISAID: EPI_ISL_406862). BioProject PRJNA716271, Sequencing of SARS-CoV-2 Isolates from BEI Resources, has been published on the NCBI website. The sequences from the BEI Resources SARS-CoV-2 isolates included in the project have been deposited into GenBank (SRA: SRP312598) and the sequence for SARS-CoV-2, isolate Germany/BavPat1/2020 (NR-52370), is available (SAMN18527784). Each vial contains approximately 0.5 mL of cell lysate and supernatant from Cercopithecus aethiops kidney cells infected with SARS-CoV-2, isolate Germany/BavPat1/2020. Additional information and tools are available at ViPR (Virus Pathogen Resource).